uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
54.31
+1.66 (3.15%)
At close: Sep 26, 2025, 4:00 PM EDT
54.03
-0.28 (-0.52%)
After-hours: Sep 26, 2025, 7:59 PM EDT
uniQure Revenue
uniQure had revenue of $5.26M in the quarter ending June 30, 2025, a decrease of -52.71%. This brings the company's revenue in the last twelve months to $14.34M, down -48.25% year-over-year. In the year 2024, uniQure had annual revenue of $27.12M with 71.17% growth.
Revenue (ttm)
$14.34M
Revenue Growth
-48.25%
P/S Ratio
195.72
Revenue / Employee
$68,598
Employees
209
Market Cap
4.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.12M | 11.28M | 71.17% |
Dec 31, 2023 | 15.84M | -90.64M | -85.12% |
Dec 31, 2022 | 106.48M | -417.52M | -79.68% |
Dec 31, 2021 | 524.00M | 486.49M | 1,296.82% |
Dec 31, 2020 | 37.51M | 30.23M | 415.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
QURE News
- 2 days ago - uniQure Announces Pricing of Upsized $300 Million Public Offering - GlobeNewsWire
- 2 days ago - UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street - Benzinga
- 2 days ago - uniQure Stock Jumps On Positive News, But Risks Remain - Benzinga
- 2 days ago - UniQure: How QURE Stock Rises 10x To $500? - Forbes
- 3 days ago - Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it - Market Watch
- 3 days ago - uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond - Seeking Alpha
- 3 days ago - uniQure Announces $200 Million Proposed Public Offering - GlobeNewsWire
- 3 days ago - uniQure N.V. - Special Call - Seeking Alpha